Target intelligence / Profile preview

Ankyrin repeat domain 30B pseudogene

Molecular classification
Pseudogene
01

Overview

The ankyrin repeat domain 30B pseudogene is a genomic sequence related to the functional ankyrin repeat domain 30B (ANKRD30B) gene but has lost the ability to code for a functional protein[2][4][6]. Pseudogenes such as this are classified based on their high similarity to protein-coding or RNA genes but are typically nonfunctional due to disabling mutations including premature stop codons or frameshifts[2][4][6]. As a pseudogene, it is not directly involved in drug targeting, functional signaling, or disease roles, and has no established use as a biomarker or therapeutic target. Notes: - If you are interested in the functional protein-coding gene, refer to "Ankyrin repeat domain 30B" (ANKRD30B), not the pseudogene, as potential targets or disease associations reported in literature are for the protein-coding form[5][1]. - As a pseudogene, ENSG00000276963 is generally not considered a therapeutic target and does not have known biological or pharmacological functions[2][4][6]. If this entry was provided as a drug or receptor target, that is likely a mistake. If specific functional roles, disease links, or drug interactions are needed, refer to the active gene ANKRD30B rather than its pseudogene.

Other names
NCRNA00164ANKRD30BP3

Beyond the preview

Go deeper on Ankyrin repeat domain 30B pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 30B pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call